Several events have been reported to be responsible for the upregulation of pro-survival Bcl-2 proteins; among the events is Bcl-2 translocation (first reported in follicular lymphoma), which is not prevalent among other cancers. This evidence concerns the gene BCL2 and follicular lymphoma.